DO & CO Aktiengesellschaft (0E64)
London Exchange · UK · prices in EUR · close of 19 Oct 2026
Key indicators
| Last close | EUR 196.20 |
|---|---|
| 52-week range | 161.97 – 228.41 |
| Return, 1 month / 3 months | +5.0% / −2.4% |
| Return, 1 year / 3 years | −7.3% / +83.9% |
| Trend | Above 200-day, below 50-day |
| RSI (14) | 52 |
| Volatility (1 year) | 40.5% |
| Worst drawdown (1 year) | -25.9% |
| Average daily value traded | 1.41M EUR |
| Dividend yield | 1.3% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
DO & CO Aktiengesellschaft is an Austrian catering and hospitality company based in Vienna. It prepares and serves food for airlines, providing in-flight catering to carriers at several airports, and it also runs restaurants, event catering operations and hotel and hospitality venues in cities including Vienna. Its customers range from airlines and event organisers to diners at its own restaurants and guests at its hospitality locations, with much of its activity centred on food preparation and service.
DO & CO Aktiengesellschaft trades under the code 0E64 on the London Exchange in UK, with its price quoted in euros (EUR). Our dividend records, which start in 2019, show payments in 5 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
DO & CO Aktiengesellschaft (0E64) trades on the London Exchange in UK. It last closed at EUR 196.20 on 19 October 2026.
Its price-based Market X-Ray is 48 out of 100 (a weak price profile), ranking 2,200 of 3,787 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price fell 7.3% and over the last three months it fell 2.4%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on London Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 57 · Fair | Mixed trend against its averages. | |
| Above 200-day average | 1.3% | ||
| From 52-week high | -13.2% | ||
| Momentum | 45 · Weak | Lagging most stocks on this exchange. | |
| 3-month return | -2.4% | ||
| 6-month return | 5.1% | ||
| 12-month return, skipping the last month | -11.7% | ||
| Stability (higher is calmer) | 49 · Weak | Volatile, with deep drawdowns. | |
| Volatility, 1 year (lower is calmer) | 40.5% | ||
| Worst drawdown, 1 year (smaller is calmer) | -25.9% | ||
| Liquidity | 56 · Fair | Moderate trading activity. | |
| Average daily value traded | 1.41M EUR | ||
| Zero-volume days | 10.0% | ||
| Income | 14 · Weak | Dividend is small or irregular. | |
| Dividend yield | 1.3% | ||
| Years with dividends | 3 |
Strengths
No lens stands out as a clear strength against its exchange.
Weak spots
- Momentum: Lagging most stocks on this exchange.
- Stability (higher is calmer): Volatile, with deep drawdowns.
- Income: Dividend is small or irregular.
Returns
| 1 week | +0.7% |
|---|---|
| 1 month | +5.0% |
| 3 months | −2.4% |
| 6 months | +5.1% |
| 1 year | −7.3% |
| 3 years | +83.9% |
| 5 years | +155.9% |
Signals
| 50-day / 200-day average | 198.13 / 193.70 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 3.24 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 28 Jul 2026 | EUR 2.5000 |
| 17 Jul 2025 | EUR 2.0000 |
| 24 Jul 2023 | EUR 1.0000 |
| 17 Jul 2020 | EUR 0.8500 |
| 22 Jul 2019 | EUR 0.8500 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on London Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.